Legal & General Group Plc lowered its stake in The Ensign Group, Inc. (NASDAQ:ENSG – Free Report) by 18.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 93,967 shares of the company’s stock after selling 21,671 shares during the period. Legal & General Group Plc’s holdings in The Ensign Group were worth $16,369,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of ENSG. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of The Ensign Group by 9.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after purchasing an additional 14,590 shares in the last quarter. Geneos Wealth Management Inc. increased its holdings in shares of The Ensign Group by 150.3% in the first quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after purchasing an additional 230 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of The Ensign Group by 65.9% in the second quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after purchasing an additional 213 shares in the last quarter. Amundi increased its holdings in shares of The Ensign Group by 480,216.7% in the second quarter. Amundi now owns 57,638 shares of the company’s stock valued at $8,583,000 after purchasing an additional 57,626 shares in the last quarter. Finally, Brown Advisory Inc. increased its holdings in shares of The Ensign Group by 26.1% in the second quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock valued at $314,000 after purchasing an additional 421 shares in the last quarter. Institutional investors and hedge funds own 96.12% of the company’s stock.
Analysts Set New Price Targets
ENSG has been the topic of a number of recent research reports. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Zacks Research lowered shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Truist Financial set a $215.00 target price on shares of The Ensign Group and gave the stock a “hold” rating in a report on Friday, February 6th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of The Ensign Group in a report on Tuesday, April 21st. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $222.00 target price (up from $206.00) on shares of The Ensign Group in a report on Monday, February 9th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $216.75.
Insiders Place Their Bets
In other news, Director Barry M. Smith sold 700 shares of The Ensign Group stock in a transaction on Thursday, April 2nd. The shares were sold at an average price of $196.65, for a total transaction of $137,655.00. Following the transaction, the director directly owned 22,152 shares of the company’s stock, valued at $4,356,190.80. This trade represents a 3.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of The Ensign Group stock in a transaction on Monday, April 20th. The stock was sold at an average price of $199.97, for a total transaction of $78,388.24. Following the transaction, the director directly owned 9,295 shares in the company, valued at approximately $1,858,721.15. This represents a 4.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 1,892 shares of company stock worth $363,250. Insiders own 4.00% of the company’s stock.
The Ensign Group Trading Down 1.6%
Shares of NASDAQ ENSG opened at $165.00 on Tuesday. The company’s fifty day moving average is $187.66 and its 200-day moving average is $188.09. The stock has a market cap of $9.64 billion, a price-to-earnings ratio of 26.87, a P/E/G ratio of 1.65 and a beta of 0.68. The Ensign Group, Inc. has a twelve month low of $134.79 and a twelve month high of $218.00. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.06.
The Ensign Group (NASDAQ:ENSG – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.79 by $0.06. The company had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.40 billion. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period last year, the firm posted $1.52 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. Equities research analysts predict that The Ensign Group, Inc. will post 6.79 EPS for the current year.
The Ensign Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st were given a dividend of $0.065 per share. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Tuesday, March 31st. The Ensign Group’s dividend payout ratio (DPR) is currently 4.23%.
The Ensign Group Company Profile
The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.
Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.
Read More
- Five stocks we like better than The Ensign Group
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Want to see what other hedge funds are holding ENSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Ensign Group, Inc. (NASDAQ:ENSG – Free Report).
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.
